<code id='44D5867C30'></code><style id='44D5867C30'></style>

<acronym id='44D5867C30'></acronym>

<center id='44D5867C30'><center id='44D5867C30'><tfoot id='44D5867C30'></tfoot></center><abbr id='44D5867C30'><dir id='44D5867C30'><tfoot id='44D5867C30'></tfoot><noframes id='44D5867C30'>

<optgroup id='44D5867C30'><strike id='44D5867C30'><sup id='44D5867C30'></sup></strike><code id='44D5867C30'></code></optgroup>

<b id='44D5867C30'><label id='44D5867C30'><select id='44D5867C30'><dt id='44D5867C30'><span id='44D5867C30'></span></dt></select></label></b><u id='44D5867C30'></u>

~~<i id='44D5867C30'><strike id='44D5867C30'><tt id='44D5867C30'><pre id='44D5867C30'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

leisure time

author：hotspot 2025-09-28 17:47:11 Page View：7876

UnitedHealth Group — UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

advertisement

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Will Ozempic
Next article： What does generative AI mean for health care? We asked experts

explore

ChatGPT in medicine: STAT answers readers' burning questions

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

Eli Lilly expects to double planned employment in Boston center

Eli Lilly expects to double planned employment in Boston center

Anartist'srenderingofthebuilding—currentlyunderconstructionalongBoston'sFortPointChannel—whereEliLil

Medical leaders decry Supreme Court decision on affirmative action

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

Unmasking the 'centricity' illusion in clinical trials

JoeRaedle/GettyImagesDuringmy25yearsworkinginclinicaltrialoperations,I’veseenthebiopharmaceuticalwor

read more